Levofloxacin

Antibiotic

Phase of research

FDA-/EMA-approved for Cystic Fibrosis

How it helps

Anti-Infective


General information

Levofloxacin is an antibiotic sold under many names, e.g. Quinsair®. It was approved for medical use in the USA in 1996. It is used to treat a number of bacterial infections including acute bacterial sinusitis, pneumonia, tuberculosis, urinary tract infections, chronic prostatitis, and gastroenteritis. In relation to cystic fibrosis, our AIM tool found the data that levofloxacin inhalation solution can be a safe and effective therapy for cystic fibrosis patients with chronic Pseudomonas aeruginosa infection.

Levofloxacin on PubChem
Levofloxacin on DrugBank
Levofloxacin on Wikipedia


Synonyms

LIS, MP-376, Aeroquin


Marketed as


Dietary sources

N/A

Structure not available

C18H20FN3O4


Drug-Mutation Relation

results for 182delT / K710X
See all data on Levofloxacin

Treats


Does not treat

Mutation Link Tested on Impact factor Notes